![](/img/cover-not-exists.png)
ACTR-17. EVOPHOSPHAMIDE (TH-302) FOR RECURRENT GBM FOLLOWING BEVACIZUMAB FAILURE, FINAL RESULTS OF A MULTICENTER PHASE II STUDY
Brenner, Andrew J, Reardon, David, Wen, Patrick, Huang, Shiliang, Fox, Peter, Muzi, Mark, Lee, EudociaVolume:
20
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noy148.051
Date:
November, 2018
File:
PDF, 121 KB
2018